Phase
Condition
Williams Syndrome
Attention Deficit/hyperactivity Disorder (Adhd - Adults)
Treatment
Conners Continuous Performance Test 3rd Edition™ (CPT 3)
ARVO 2.0 WEB
Clinical Study ID
Ages 8-13 All Genders Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
ADHD group
The Inclusion criteria:
Signed informed consent (by guardian and a child)
Age of 8-13 at the time of consent
ADHD set by a licensed physician
Native language Finnish / Fluent Finnish language
TD group
The Inclusion criteria:
Signed informed consent (by guardian and child)
Age of 8-13 at the time of the consent
Native language Finnish / Fluent Finnish language
Exclusion
Exclusion Criteria:
ADHD group
Any diseases of the nervous system (ICD-10, G00-G99)
Mental and behavioural disorders due to psychoactive substance use (F10-F19)
Schizophrenia, schizotypal and delusional disorders (F20 - F29)
Acute severe depression or mania / hypomania (F30, F32, F33)
Phobic anxiety disorders, other anxiety disorders, obsessive-compulsive disorder (F40-F42)
Severe mental retardation (F72)
Disorders of psychological development (F80, F81, F83, F84)
Medication taken for ADHD (methylphenidate, lisdexamfetamine) on the test day (24hour wash out)
Atomoxetine, guanfacine
Hearing or vision diagnosis (H90 Bilateral hearing loss, H53 Visual disturbances,H54 Blindness and low vision) Diagnosis search completeness criteria: Diagnosispresent/absent in patient registry Kanta.
TD group
Set ADHD diagnosis.
Ongoing process related to setting an ADHD diagnosis, according to guardian'squestionnaire.
Any diseases of the nervous system (ICD-10, G00-G99)
Mental and behavioural disorders due to psychoactive substance use (F10-F19)
Schizophrenia, schizotypal and delusional disorders (F20 - F29)
Acute severe depression or mania / hypomania (F30, F32, F33)
Phobic anxiety disorders, other anxiety disorders, obsessive-compulsive disorder (F40-F42)
Severe mental retardation (F72)
Disorders of psychological development (F80, F81, F83, F84)
Hearing or vision diagnosis (H90 Bilateral hearing loss, H53 Visual disturbances,H54 Blindness and low vision)
Study Design
Connect with a study center
Pro Neuron Oy
Espoo, 02650
FinlandSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.